Signal Diagnostics LLC has agreed to pay $20.5 million to settle allegations that it violated the False Claims Act by retaining overpayments to the HRSA Uninsured Program.
Why it matters. The settlement affects Signal Diagnostics and highlights the risks of non-compliance with healthcare regulations, impacting the company's financial health and reputation.
Signal Diagnostics LLC (Signal) has agreed to pay the United States $20.5 million to resolve allegations that Signal violated the False Claims Act by knowingly retaining and improperly avoiding its obligations to repay the Health Resources & Services Administration (HRSA) COVID-19 Claims Reimbursement to Health Care
Signal Diagnostics LLC (Signal) has agreed to pay the United States $20.5 million to resolve allegations that Signal violated the False Claims Act by knowingly retaining and improperly avoiding its obligations to repay the Health Resources & Services Administration (HRSA) COVID-19 Claims Reimbursement to Health Care Providers and Facilities for Testing, Treatment, and Vaccine Administration for t…
Independence Blue Cross (IBX), an insurance company incorporated under the laws of Pennsylvania, has agreed to pay $22.5 million to resolve allegations that it violated the False Claims Act by...
